Cefalotin
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a682860 |
Pregnancy category | |
Routes of administration | Intravenous |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | n/a |
Protein binding | 65 to 80% |
Metabolism | Hepatic |
Elimination half-life | 30 minutes to 1 hour |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C16H16N2O6S2 |
Molar mass | 396.44 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Cefalotin |
Articles |
---|
Most recent articles on Cefalotin |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cefalotin at Clinical Trials.gov Clinical Trials on Cefalotin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cefalotin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cefalotin Discussion groups on Cefalotin Directions to Hospitals Treating Cefalotin Risk calculators and risk factors for Cefalotin
|
Healthcare Provider Resources |
Causes & Risk Factors for Cefalotin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cefalotin (INN) (Template:PronEng) or cephalothin (USAN) (Template:IPA) is a first-generation cephalosporin antibiotic. It was the first cephalosporin marketed and continues to be widely used. It is an intravenously-administered agent with a similar antimicrobial spectrum to cefazolin and the oral agent cefalexin. Cefalotin sodium is commonly marketed under the trade name Keflin (Lilly).